Capricor Therapeutics (CAPR) PT Raised to $25 at Ladenburg Thalmann
Ladenburg Thalmann analyst Aydin Huseynov raised the price target on Capricor Therapeutics (NASDAQ: CAPR) to $25.00 (from $24.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)